BeStock  
Stocks › Biotechnology › RIGL

Rigel Pharmaceuticals RIGL

US equityMarket cap rank #3311Biotechnology
$47.99 +$1.88 (+4.08%)
Pre-market · Oct 8, 8:40 am ET · After hours $47.00 -2.06%
Open$45.64
Prev close$46.11
Day range$45.22 – $48.15
Volume232.6K
Market cap$896.45M
P/E (TTM)2.8
Dividend yield–

RIGL Stock News

Headlines matching Rigel Pharmaceuticals or the RIGL ticker, most recent first.

  • Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $83 PositiveMarket news · 6 Aug 2026 · Direct mention
  • Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $83Market news · 6 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57Market news · 5 Aug 2026 · Direct mention
  • Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $43 PositiveMarket news · 5 Aug 2026 · Direct mention
  • Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $49 PositiveMarket news · 17 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $85 PositiveMarket news · 14 Aug 2026 · Direct mention
  • Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Cuts Target Price to $69 NegativeMarket news · 7 May 2026 · Direct mention
  • Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $81Market news · 13 May 2026 · Direct mention
  • Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $81 PositiveMarket news · 13 May 2026 · Direct mention
  • Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Maintains Target Price $40Market news · 13 May 2026 · Direct mention
  • Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Cuts Target Price to $40 NegativeMarket news · 24 Apr 2026 · Direct mention
  • Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $71Market news · 4 Mar 2026 · Direct mention
  • Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Maintains Target Price $38Market news · 4 Mar 2026 · Direct mention
  • Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $42 PositiveMarket news · 6 Feb 2026 · Direct mention
  • H.C. Wainwright Sticks to Their Buy Rating for Rigel (RIGL)TipRanks · 5 Oct 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on RIGL.

Leave a comment

Scroll to Top